Ovar it.

Yet another large analysis, this one a meta-analysis of systemic therapy trials for women with advanced ovarian cancer, indicates progression-free survival means little to nothing if not followed-on by confirmatory overall-survival measures. | Paoletti, JAMA Netw Open 2020